A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer ...

Teos Therapeutics has potential lung cancer treatment despite issues and strong financial position. Read here to know why we ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

Union, joined at a press conference Monday by Brad Schnure, a 48-year-old former senior state employee who is battling stage IV lung cancer, said he has a solution to frustrating denials: Pass ...

Jazz Pharmaceuticals announced that the FDA has approved ZIIHERA® (zanidatamab-hrii) on an accelerated basis for the treatment ...

The FDA granted breakthrough therapy designation to sacituzumab govitecan for patients with ES-SCLC progressing on platinum ...

Bobbi Conner talks with MUSC's Dr. Tucker Marrison about cancer screening recommendations for adults, with an update about ...

Doctors at Chesapeake Regional Healthcare are able to minimize the pain lung cancer patients undergo with a one-and-done ...

The U.S. Preventive Services Task Force recommends a low-dose CT scan of the chest for anyone who is between ages 50 and 80 ...

Puma Biotechnology faces challenges but has a solid financial base. Learn why PBYI stock is a "Buy" with potential upside ...

Some 90% of investigational drugs fail—and success rates are even more dire in the neuro space. Here, BioSpace looks at five ...

Recent cancer treatment breakthroughs include FDA approvals for zenocutuzumab and durvalumab, and sacituzumab tirumotecan gained breakthrough therapy status. In addition, sonodynamic therapy shows ...